Pascale Dehertogh

1.5k citations

19 papers · 1.1k indexed · h-index 16

Co-authors: Jan Martin Berke Karen Vergauwen Frederik Pauwels Kurt Hertogs Wendy Mostmans Koen Vandyck Pierre Raboisson Brendan Larder
Topics: HIV/AIDS drug development and treatment (14 papers)Hepatitis C virus research (11 papers)HIV Research and Treatment (10 papers)
Cited by: Virology Hepatology Infectious Diseases
Journals: Journal of Virology Journal of Medicinal Chemistry Antimicrobial Agents and Chemotherapy
Partner nations: Belgium United States Sweden

In The Last Decade

Pascale Dehertogh

19 papers receiving 1.1k citations

Peers

Countries citing papers authored by Pascale Dehertogh

Since Specialization

Citations

This map shows the geographic impact of Pascale Dehertogh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascale Dehertogh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascale Dehertogh more than expected).

Fields of papers citing papers by Pascale Dehertogh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascale Dehertogh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascale Dehertogh. The network helps show where Pascale Dehertogh may publish in the future.

Co-authorship network of co-authors of Pascale Dehertogh

This figure shows the co-authorship network connecting the top 25 collaborators of Pascale Dehertogh. A scholar is included among the top collaborators of Pascale Dehertogh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascale Dehertogh. Pascale Dehertogh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Antiviral Properties and Mechanism of Action Studies of the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379 2020 ·Antimicrobial Agents and Chemotherapy ·Jan Martin Berke,Pascale Dehertogh,Karen Vergauwen,Wendy Mostmans,Koen Vandyck,Pierre Raboisson,Frederik Pauwels	55
2	Anti-HBV activity of the HBV capsid assembly modulator JNJ-56136379 across full-length genotype A–H clinical isolates and core site-directed mutants in vitro 2020 ·Journal of Antimicrobial Chemotherapy ·Thierry Verbinnen,(unknown),(unknown),Pascale Dehertogh,Karen Vergauwen,Jean‐Marc Neefs,Edgar Jacoby,Oliver Lenz,Jan Martin Berke	22
3	Synthesis and Evaluation of N-Phenyl-3-sulfamoyl-benzamide Derivatives as Capsid Assembly Modulators Inhibiting Hepatitis B Virus (HBV) 2018 ·Journal of Medicinal Chemistry ·Koen Vandyck,Geert Rombouts,Bart Stoops,Abdellah Tahri,Ann Vos,(unknown),Yiming Wu,(unknown),(unknown),(unknown),Karen Vergauwen,Pascale Dehertogh,Jan Martin Berke,Pierre Raboisson	42
4	Antiviral profiling of the capsid assembly modulator BAY41-4109 on full-length HBV genotype A-H clinical isolates and core site-directed mutants in vitro 2017 ·Antiviral Research ·Jan Martin Berke,(unknown),Thierry Verbinnen,Pascale Dehertogh,Karen Vergauwen,Ann Vos,Oliver Lenz,Frederik Pauwels	25
5	Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B Virus 2017 ·Antimicrobial Agents and Chemotherapy ·Jan Martin Berke,Pascale Dehertogh,Karen Vergauwen,Ellen Van Damme,Wendy Mostmans,Koen Vandyck,Frederik Pauwels	116
6	Identification of HIV-1 Reverse Transcriptase Inhibitors Using a Scintillation Proximity Assay 2013 ·Methods in molecular biology ·(unknown),Marnix Van Loock,Tania Ivens,Pascale Dehertogh,Dirk Jochmans,(unknown)	1
7	TMC647055, a Potent Nonnucleoside Hepatitis C Virus NS5B Polymerase Inhibitor with Cross-Genotypic Coverage 2012 ·Antimicrobial Agents and Chemotherapy ·Benoit Devogelaere,Jan Martin Berke,Leen Vijgen,Pascale Dehertogh,Els Fransen,Erna Cleiren,Liesbet van der Helm,Origène Nyanguile,Abdellah Tahri,Katie Amssoms,Oliver Lenz,Maxwell D. Cummings,R. Clayton,Sandrine Vendeville,Pierre Raboisson,Kenneth Simmen,Gregory Fanning,(unknown)	31
8	Antiviral Activity and Mode of Action of TMC647078, a Novel Nucleoside Inhibitor of the Hepatitis C Virus NS5B Polymerase 2011 ·Antimicrobial Agents and Chemotherapy ·Jan Martin Berke,Leen Vijgen,Sophie Lachau‐Durand,Megan H. Powdrill,(unknown),(unknown),Staffan Eriksson,Matthias Götte,Els Fransen,Pascale Dehertogh,Christel Van den Eynde,Laurent Leclercq,Tim H. M. Jonckers,Pierre Raboisson,Magnus Nilsson,Bertil Samuelsson,Åsa Rosenquist,Gregory Fanning,Tse‐I Lin	6
9	In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435 2010 ·Antimicrobial Agents and Chemotherapy ·Oliver Lenz,Thierry Verbinnen,Tse‐I Lin,Leen Vijgen,Maxwell D. Cummings,Jimmy Lindberg,Jan Martin Berke,Pascale Dehertogh,Els Fransen,Annick Scholliers,Katrien Vermeiren,Tania Ivens,Pierre Raboisson,Michael Edlund,(unknown),Lotta Vrang,Herman de Kock,Gregory Fanning,Kenneth Simmen	178
10	Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories 2008 ·European Journal of Pharmaceutical Sciences ·Rose Hayeshi,Constanze Hilgendorf,Per Artursson,Patrick Augustijns,Birger Brodin,Pascale Dehertogh,Karen A. Fisher,(unknown),Egbert Hovenkamp,Timo Korjamo,Chantal Masungi,Nathalie Maubon,Raf Mols,Anette Müllertz,Jukka Mönkkönen,Caitríona M. O’Driscoll,(unknown),Eva Ragnarsson,Martijn Rooseboom,Anna‐Lena Ungell	199
11	1,5-Benzodiazepines, a Novel Class of Hepatitis C Virus Polymerase Nonnucleoside Inhibitors 2008 ·Antimicrobial Agents and Chemotherapy ·Origène Nyanguile,Frederik Pauwels,(unknown),Carlo Boutton,(unknown),Tania Ivens,Liesbet van der Helm,(unknown),Wendy Mostmans,Frédéric Delouvroy,Pascale Dehertogh,Maxwell D. Cummings,(unknown),Kenneth Simmen,Pierre Raboisson	37
12	Indolopyridones Inhibit Human Immunodeficiency Virus Reverse Transcriptase with a Novel Mechanism of Action 2006 ·Journal of Virology ·Dirk Jochmans,Jérôme Deval,Bart Kesteleyn,Herwig Van Marck,(unknown),(unknown),Pascale Dehertogh,Tania Ivens,Marcia Van Ginderen,(unknown),Maryam Ehteshami,Piet Wigerinck,Matthias Götte,Kurt Hertogs	77
13	Plasma drug levels, genotypic resistance, and virological response to a nelfinavir plus saquinavir-containing regimen 2002 ·AIDS ·José L. Casado,Santiago Moreno,Kurt Hertogs,Fernando Dronda,Antonio Antela,Pascale Dehertogh,Maria Jesús Pérez‐Elías,Ana Moreno	20
14	Efficacy, Tolerance, and Pharmacokinetics of the Combination of Stavudine, Nevirapine, Nelfinavir, and Saquinavir as Salvage Regimen after Ritonavir or Indinavir Failure 2001 ·AIDS Research and Human Retroviruses ·José L. Casado,Fernando Dronda,Kurt Hertogs,(unknown),Antonio Antela,Paloma Martí-Belda,Pascale Dehertogh,Santiago Moreno	12
15	Genotypic and Phenotypic Evidence of Different Drug-Resistance Mutation Patterns between B and Non-B Subtype Isolates of Human Immunodeficiency Virus Type 1 found in Brazilian Patients Failing HAART 2001 ·Virus Genes ·Elena Caride,Kurt Hertogs,Brendan Larder,Pascale Dehertogh,(unknown),Elizabeth S. Machado,(unknown),Walter de Araújo Eyer-Silva,Fernando Samuel Sion,(unknown),(unknown),(unknown),Amílcar Tanuri	46
16	Resistance to Antiretroviral Therapy Among Patients in Uganda 2001 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Paul J. Weidle,Cissy Kityo,Peter Mugyenyi,Robert Downing,(unknown),Danuta Pieniążek,Richard Respess,Kurt Hertogs,Véronique De Vroey,Pascale Dehertogh,Stuart Bloor,Brendan Larder,Eve Lackritz	16
17	Resistance to Antiretroviral Therapy Among Patients in Uganda 2001 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Paul J. Weidle,Cissy Kityo,Peter Mugyenyi,Robert Downing,(unknown),Danuta Pieniążek,Richard Respess,Kurt Hertogs,Véronique De Vroey,Pascale Dehertogh,Stuart Bloor,Brendan Larder,Eve Lackritz	38
18	Drug-Resistant Reverse Transcriptase Genotyping and Phenotyping of B and Non-B Subtypes (F and A) of Human Immunodeficiency Virus Type I Found in Brazilian Patients Failing HAART 2000 ·Virology ·Elena Caride,Rodrigo Brindeiro,Kurt Hertogs,Brendan Larder,Pascale Dehertogh,Elizabeth S. Machado,(unknown),Walter de Araújo Eyer-Silva,Fernando Samuel Sion,(unknown),(unknown),(unknown),Amílcar Tanuri	61
19	A Novel Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutational Pattern Confers Phenotypic Lamivudine Resistance in the Absence of Mutation 184V 2000 ·Antimicrobial Agents and Chemotherapy ·Kurt Hertogs,Stuart Bloor,Véronique De Vroey,Christel Van den Eynde,Pascale Dehertogh,(unknown),Martin Stürmer,Timothy M. Alcorn,Scott A. Wegner,Margriet Van Houtte,Veronica Miller,Brendan Larder	102

About Pascale Dehertogh

Pascale Dehertogh is a scholar working on Virology, Hepatology and Infectious Diseases, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (14 papers), Hepatitis C virus research (11 papers) and HIV Research and Treatment (10 papers). The work is most often cited by research in Virology (363 citations), Hepatology (437 citations) and Infectious Diseases (601 citations). Pascale Dehertogh has collaborated with scholars based in Belgium, United States and Sweden. Frequent co-authors include Jan Martin Berke, Karen Vergauwen, Frederik Pauwels, Kurt Hertogs, Wendy Mostmans, Koen Vandyck, Pierre Raboisson, Brendan Larder, Tania Ivens and Oliver Lenz. Their work appears in journals such as Journal of Virology, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact